Cargando…

Tumor Suppressors Having Oncogenic Functions: The Double Agents

Cancer progression involves multiple genetic and epigenetic events, which involve gain-of-functions of oncogenes and loss-of-functions of tumor suppressor genes. Classical tumor suppressor genes are recessive in nature, anti-proliferative, and frequently found inactivated or mutated in cancers. Howe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Datta, Neerajana, Chakraborty, Shrabastee, Basu, Malini, Ghosh, Mrinal K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824251/ https://www.ncbi.nlm.nih.gov/pubmed/33396222 http://dx.doi.org/10.3390/cells10010046

Ejemplares similares

Chaperone-assisted E3 ligase CHIP: A double agent in cancer
por: Kumar, Sunny, et al.
Publicado: (2021)

Double agents: genes with both oncogenic and tumor-suppressor functions
por: Shen, Libing, et al.
Publicado: (2018)

Double Agent: SPDEF Gene with Both Oncogenic and Tumor-Suppressor Functions in Breast Cancer
por: Ye, Ting, et al.
Publicado: (2020)

VAV Proteins as Double Agents in Cancer: Oncogenes with Tumor Suppressor Roles
por: Cuadrado, Myriam, et al.
Publicado: (2021)

Emerging insights into HAUSP (USP7) in physiology, cancer and other diseases
por: Bhattacharya, Seemana, et al.
Publicado: (2018)

Promyelocytic Leukemia (PML) gene regulation: implication towards curbing oncogenesis
por: Datta, Neerajana, et al.
Publicado: (2019)

The interrelationship between cerebral ischemic stroke and glioma: a comprehensive study of recent reports
por: Ghosh, Mrinal K., et al.
Publicado: (2019)

RUNX family: Oncogenes or tumor suppressors
por: Otálora-Otálora, Beatriz Andrea, et al.
Publicado: (2019)

Angiomotin Family Members: Oncogenes or Tumor Suppressors?
por: Lv, Meng, et al.
Publicado: (2017)

SIRT3: Oncogene and Tumor Suppressor in Cancer
por: Torrens-Mas, Margalida, et al.
Publicado: (2017)

Neurological damages in COVID‐19 patients: Mechanisms and preventive interventions
por: Sarkar, Sibani, et al.
Publicado: (2023)

Tumor-Suppressor Genes and Oncogenes
Publicado: (1993)

Oncogenes and tumor-suppressor genes.
por: Lehman, T A, et al.
Publicado: (1991)

RhoB: Team Oncogene or Team Tumor Suppressor?
por: Ju, Julia A., et al.
Publicado: (2018)

Oncogenic and tumor suppressor function of MEIS and associated factors
por: GİRGİN, Birkan, et al.
Publicado: (2020)

COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery
por: Kumar, Sunny, et al.
Publicado: (2023)

COVID-19 and cancer: insights into their association and influence on genetic and epigenetic landscape
por: Ghosh, Mrinal K, et al.
Publicado: (2023)

Genetic Basis for Carcinogenesis. Tumor Suppressor Genes and Oncogenes
por: Rabbitts, P.
Publicado: (1992)

Oncogenes and Tumor Suppressors Regulate Glutamine Metabolism in Cancer Cells
por: Kim, Min Hyun, et al.
Publicado: (2013)

Dysregulation of Glucose Metabolism by Oncogenes and Tumor Suppressors in Cancer Cells
por: Marbaniang, Casterland, et al.
Publicado: (2018)

Myosin Heavy Chain 9: Oncogene or Tumor Suppressor Gene?
por: Wang, Yunmei, et al.
Publicado: (2019)

Targeting PD-1/PD-L1 in cancer immunotherapy: An effective strategy for treatment of triple-negative breast cancer (TNBC) patients
por: Kumar, Sunny, et al.
Publicado: (2022)

NOTCH receptors in gastric and other gastrointestinal cancers: oncogenes or tumor suppressors?
por: Huang, Tingting, et al.
Publicado: (2016)

Tumor suppressor and oncogenic role of long non-coding RNAs in cancer
por: Guzel, Esra, et al.
Publicado: (2019)

KRAB-ZFP Transcriptional Regulators Acting as Oncogenes and Tumor Suppressors: An Overview
por: Sobocińska, Joanna, et al.
Publicado: (2021)

At the double for tumor suppressor
por: Sonawane, Mahendra
Publicado: (2016)

Cellular senescence checkpoint function determines differential Notch1-dependent oncogenic and tumor suppressor activities
por: Kagawa, Shingo, et al.
Publicado: (2014)

TRAP1 Regulation of Cancer Metabolism: Dual Role as Oncogene or Tumor Suppressor
por: Matassa, Danilo Swann, et al.
Publicado: (2018)

The Mitotic Cancer Target Polo-Like Kinase 1: Oncogene or Tumor Suppressor?
por: de Cárcer, Guillermo
Publicado: (2019)

A Double-Edged Sword: How Oncogenes and Tumor Suppressor Genes Can Contribute to Chromosomal Instability
por: Orr, Bernardo, et al.
Publicado: (2013)

Oncogenes and tumor-suppressor genes in mesothelioma--a synopsis.
por: Lechner, J F, et al.
Publicado: (1997)

Is miR-29 an oncogene or tumor suppressor in CLL?
por: Pekarsky, Yuri, et al.
Publicado: (2010)

IGF-Binding Protein 2 – Oncogene or Tumor Suppressor?
por: Pickard, Adam, et al.
Publicado: (2015)

Somatic selection distinguishes oncogenes and tumor suppressor genes
por: Chandrashekar, Pramod, et al.
Publicado: (2019)

Novel oncogenes and tumor suppressor genes in hepatocellular carcinoma
por: Wang, Fang, et al.
Publicado: (2021)

Major Tumor Suppressor and Oncogenic Non-Coding RNAs: Clinical Relevance in Lung Cancer
por: Inamura, Kentaro
Publicado: (2017)

USP28: Oncogene or Tumor Suppressor? A Unifying Paradigm for Squamous Cell Carcinoma
por: Prieto-Garcia, Cristian, et al.
Publicado: (2021)

Downstream of the HOX genes: Explaining conflicting tumour suppressor and oncogenic functions in cancer
por: Morgan, Richard, et al.
Publicado: (2022)

Genomic imbalances pinpoint potential oncogenes and tumor suppressors in Wilms tumors
por: Krepischi, A. C. V., et al.
Publicado: (2016)

Oncogenic and tumor suppressor functions of Notch in cancer: it’s NOTCH what you think
por: Lobry, Camille, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_rf80cs35dvu2jjfijih9rh3liv